BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

  Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is in advanced discussions, with Scottish Enterprise, for a multi-million pound grant which will enable it to fully complete its strategic manufacturing site in Livingston, Scotland.

  December 23, 2021

   · 

  6 min read
• CVR Medical Corp. Announces Closing of Capital Raise

  The Closing consisted of 3,850,000 units at a price CDN$0.030 per unit for gross proceeds of CDN$115,500, as a result of the Exchange’s acceptance of the Company’s application for a discretionary waiver of the $0.05 minimum pricing requirement.

  December 23, 2021

   · 

  4 min read
• Oncorena Secures Financing of the Company’s Continued Development of Orellanine, a Potential Breakthrough Therapy for Advanced Renal Cancer

  Oncorena, developing a potential breakthrough therapy for advanced renal cancer, receives a capital injection of MSEK 66 from one of the company’s principal shareholders together with two new investors.

  December 23, 2021

   · 

  4 min read
• Nordic Nanovector ASA: Financial Calendar for 2022

  Nordic Nanovector ASA, a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces its Financial Calendar for 2022.

  December 23, 2021

   · 

  1 min read
• Philips and IJsselland Hospital sign long-term technology partnership

  Royal Philips, a global leader in health technology, announced it has signed a 12-year strategic partnership with IJsselland Hospital.

  December 23, 2021

   · 

  2 min read
• Pharm Country

  Cyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conference

  Cyclacel Pharmaceuticals, Inc. today announced that the Company will participate in the Biotech Showcase 2022 Virtual Conference to be held January 10-12, 2022.

  December 23, 2021

   · 

  3 min read
• Drug Development

  Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder

  Tryp Therapeutics announced today the receipt of correspondence from the U.S. Food and Drug Administration (FDA) affirming the Company’s ability to proceed with a Phase 2a clinical trial evaluating the use of synthetic psilocybin for binge eating disorder.

  December 23, 2021

   · 

  4 min read
• InnovAge Announces Audit Sanctions In Colorado And Withdraws Guidance

  InnovAge Holding Corp. announced today that the Centers for Medicare and Medicaid Services (CMS) has sanctioned the Company’s Colorado centers based on deficiencies detected in a focused audit.

  December 23, 2021

   · 

  2 min read
• Veterinary Diagnostic Imaging Market Size, Share, Trends | Industry Growth and Forecast 2021-2028

  The industry analysis report is considered a valuable source of information about the global Veterinary Diagnostic Imaging industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

  December 23, 2021

   · 

  6 min read
• Drug Development

  Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

  Luye Pharma Group released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets, at the 19th National Psychiatry Conference of the Chinese Medical Association.

  December 23, 2021

   · 

  8 min read